Caplin Point Laboratories Ltd - Share Price
CAPLIPOINT
Caplin Point Laboratories LtdFinancials
Caplin Point Laboratories LtdNews & Updates
Caplin Steriles gets USFDA nod for Labetalol Hydrochloride injection USP
Sep 08,2021 03:22 PM
Labetalol Hydrochloride Injection USP is indicated for the control of blood pressure in severe hypertension.
Caplin Point Lab gains after USFDA nod for labetalol hydrochloride injection Sep 08,2021
Caplin Steriles receives USFDA approval for Labetalol Hydrochloride Injection Sep 08,2021
Markets close higher; Midcap stocks underperformed Aug 23,2021
Caplin Point Lab's subsidiary receives nod from Brazil's ANVISA for sterile injectable manufacturing site Aug 17,2021
Caplin Point subsidiary gets approval from Brazils ANVISA Aug 17,2021
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 769.90 | 87.73 | 184,808.78 | 419.30 | 0.97 | 3,312.54 | 104.36 |
| Divis Laboratories Ltd | 5,122.80 | 67.55 | 136,069.90 | 551.97 | 0.39 | 1,950.16 | 349.25 |
| Dr Reddys Laboratories Ltd | 4,884.55 | 49.31 | 81,345.47 | 413.40 | 0.51 | 3,410.10 | 1,032.60 |
| Cipla Ltd | 954.05 | 29.05 | 76,966.86 | 791.77 | 0.52 | 3,948.33 | 247.04 |
| Gland Pharma Ltd | 3,962.90 | 63.11 | 65,258.82 | 350.68 | 0.00 | 1,153.90 | 359.44 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Caplin Point Laboratories LtdSummary & Reports
Incorporated in the year 16th April, 1990 Caplin Point Laboratories was promoted by P C Partheeban, T Palanisamy, S Karunakaran, S Jayaraman and B A Ahmed. The company manufactures pharmaceutical formulations in the form of tablets, ointments and capsules, liquid orals and oral powders. As on 31 March 2019, the Company has four subsidiaries, viz Caplin Steriles Limited, Argus Salud Pharma LLP, Caplin Point Far East Limited - Hongkong a... More
Registered Office
Ashvich Towers 3rd Floor,No 3 Developed Plots Ind Estat,Chennai, Tamil Nadu,600096
Tell. : +91-44-24968000
Website : http://www.caplinpoint.net
Email : investor@caplinpoint.net/info@caplinepoint.net
Registrar Office
2nd Floor Kences Tow, Usman Road T.Nagar, Chennai-600017 INDIA
Tell. : +91-44-28140801/803
Website : www.integratedindia.in
Email : sureshbabu@iepindia.com/yesbalu@iepindia.com
Reports by caplin-point-laboratories-ltd-share-price
Latest Release by caplin-point-laboratories-ltd-share-price
Result Express
Sep 18, 2021 12:01 PM
The company’s consolidated revenue stood at Rs155.86cr, up 18.7% yoy and 6.42% qoq.
Shareholding Snapshot
Loading ...
| Jun - 2021 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 69.03% |
| Total Promoter | 69.03% |
| Non Promoter | - |
| Institutions | 2.63% |
| Non-Institutions | 28.34% |
| Total Non-Promoter | 30.97% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
05 Aug 2021
Annc. Date
30 Jul 2021
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Com... More
Purpose
Dividend
Annc. Date
06 May 2021
Effective. Date
18 May 2021
Divi. Type
Interim
Divi.(%)
75
Divi. Amt.
1.5
Outcome of Board MeetingCaplin Point Laboratories Ltd has informed BSE that the Board of Directors o... More
Purpose
Board Meeting
Exp. Date
06 May 2021
Annc. Date
30 Apr 2021
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Com... More
